348 results found.
                    
AxioMed and NanoFUSE Biologics to be Available for Acquisition
KICVentures seeks funding to prepare its portfolio companies, AxioMed and NanoFUSE Biologics, to be acquis...
Alphatec Announces Stay of Proceedings In NuVasive Patent Lawsuit
Alphatec announced favorable developments in its ongoing patent litigation with NuVasive regarding CoRoent® late...
Smith & Nephew Reports 4Q18 Orthopedic Revenue of $911.8MM, +1.4% vs. 4Q17
Smith & Nephew reports 4Q18 orthopedic revenue of USD $911.8MM, +1.4% vs. 4Q1...
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical Report Preliminary 4Q18 and FY 2018 Results
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical reported preliminary 4Q18 and FY 2018 results.
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
2018 Year in Review: Revenue Projections and Technology Trends
By Mike Evers In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies, shown here in Exhibit 1. Sales for these 25 companies account for approximately 80% of the worldwide orthopaedic market. We p...
NuVasive Gains FDA Clearance for Monolith Corpectomy
NuVasive received FDA 510(k) clearance to market an expanded indication for the Monolith® corpectomy system...
NuVasive Launches Brigade for ALIF Surgery
NuVasive announced U.S. commercial launch of the Brigade® Lateral device for lateral anterior lumbar interbody fusio...
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
Alphatec Spine Reports 3Q18 Revenue of $23MM, -0.4% vs. 3Q17
Alphatec Spine reports 3Q18 revenue of US $23MM, -0.4% vs. 3Q17.
NuVasive Gains FDA Clearance for COHERE in XLIF
NuVasive received FDA 510(k) clearance for the COHERE® Porous PEEK™ device in eXtreme Lateral Interbody Fusion
Smith & Nephew Reports 3Q18 Orthopaedic Revenue of $808.7MM, +2.0% vs. 3Q17
Smith & Nephew reports 3Q18 orthopaedic revenue of US $808.7MM, +2.0% vs. 3Q17
Siemens Healthineers Gains FDA Clearance for Cios Spine Mobile C-Arm
Siemens Healthineers received FDA clearance to market Cios Spin, a mobile C-arm that provides interoper...
NuVasive Reports 3Q18 Revenue of $271.3MM, +9.6% vs. 3Q17
NuVasive performance driven by increased case volume and new products, posts 3Q18 revenue of US $271.3MM, +9.6%vs. 3Q17. ...
Zimmer Biomet Names Ivan Tornos New Group President, Orthopedics
Zimmer Biomet appointed Mr. Ivan Tornos as Group President, Orthopedics, effective November 1.
NuVasive Announces New CEO
NuVasive named J. Christopher Barry to succeed Gregory T. Lucier as Chief Executive Officer, effective next month. Mr. Lucier wil...
NuVasive Awarded Neuromonitoring Services Contract with Premier
NuVasive Clinical Services was awarded a three-year, sole source supplier contract for Intraoperative Neuromonitoring
NuVasive Enters Partnership with Biedermann Technologies
NuVasive entered into a strategic partnership with Biedermann Technologies to integrate proprietary screw techno...
NASS Conversations Reaffirm Spine’s Focus on Additive, Computer-Assisted, Materials
By Carolyn LaWell Speaking with device companies, suppliers and surgeons at the North American Spine Society Annual Meeting (NASS) confirmed our previous thoughts on the health of the spine market and the technologies driving its growth—additive manufacturing, robotics and surface...
NuVasive Enrolls Patients in Advanced Materials Science in XLIF Study
NuVasive commenced patient enrollment in a prospective, multicenter U.S. study evaluating advanced spinal impla...
NuVasive Launches New Orthobiologic Products
NuVasive commenced U.S. launch of three new biologic products for spine, including traditional bone allograft, an
Spine Company M&A Picks Up in 3Q18
By Rob Meyer and Julie A. Vetalice Eight—yes, eight—spine acquisitions were announced in the four weeks since we published our analysis, “
NuVasive Launches MAGEC X in UK
NuVasive commenced U.K. launch of MAGEC X, an extension of its MAGEC line to treat Early Onset Scoliosis. 
Globus Medical Acquires Nemaris, Surgimap Software
Globus Medical is acquiring Nemaris, developer of Surgimap® software used to preoperatively plan spine surgery...
Spine Company Sales: ORTHOWORLD Top Ten
Spine...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group